Hisayuki Katsuyama

Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial

S. Kahl, Sofiya Gancheva, Klaus Straßburger et al. · Diabetes Care · 2019 · 343 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial

Kohjiro Ueki, Takayoshi Sasako, Yukiko Okazaki et al. · The Lancet Diabetes & Endocrinology · 2017 · 309 citations

Medicine, Cardiology, Internal Medicine +13

Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice

Atsushi Obata, Naoto Kubota, Tetsuya Kubota et al. · Endocrinology · 2015 · 146 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Association of handgrip strength with hospitalization, cardiovascular events, and mortality in Japanese patients with type 2 diabetes

Hidetaka Hamasaki, Yu Kawashima, Hisayuki Katsuyama et al. · Scientific Reports · 2017 · 108 citations · Full text

Medicine, Geriatric Medicine, Internal Medicine +17

TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass

Iseki Takamoto, Naoto Kubota, Keizo Nakaya et al. · Diabetologia · 2013 · 86 citations · Full text

Life Sciences, Endocrinology, Physiology +17